[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2940087B1 - ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES. - Google Patents

ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES.

Info

Publication number
FR2940087B1
FR2940087B1 FR0858777A FR0858777A FR2940087B1 FR 2940087 B1 FR2940087 B1 FR 2940087B1 FR 0858777 A FR0858777 A FR 0858777A FR 0858777 A FR0858777 A FR 0858777A FR 2940087 B1 FR2940087 B1 FR 2940087B1
Authority
FR
France
Prior art keywords
preparation
factor viii
containing factor
erythrocytes containing
erythrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0858777A
Other languages
French (fr)
Other versions
FR2940087A1 (en
Inventor
Jean Francois Prost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Priority to FR0858777A priority Critical patent/FR2940087B1/en
Priority to PCT/FR2009/052608 priority patent/WO2010076517A1/en
Publication of FR2940087A1 publication Critical patent/FR2940087A1/en
Application granted granted Critical
Publication of FR2940087B1 publication Critical patent/FR2940087B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0858777A 2008-12-18 2008-12-18 ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES. Expired - Fee Related FR2940087B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0858777A FR2940087B1 (en) 2008-12-18 2008-12-18 ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES.
PCT/FR2009/052608 WO2010076517A1 (en) 2008-12-18 2009-12-18 Erythrocytes containing factor viii, preparation and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0858777A FR2940087B1 (en) 2008-12-18 2008-12-18 ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES.

Publications (2)

Publication Number Publication Date
FR2940087A1 FR2940087A1 (en) 2010-06-25
FR2940087B1 true FR2940087B1 (en) 2011-05-06

Family

ID=40636702

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0858777A Expired - Fee Related FR2940087B1 (en) 2008-12-18 2008-12-18 ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES.

Country Status (2)

Country Link
FR (1) FR2940087B1 (en)
WO (1) WO2010076517A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CN103282380B (en) 2010-08-10 2018-02-16 洛桑聚合联合学院 Erythrocyte binding therapeutic agent
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
LT3107563T (en) 2014-02-21 2021-07-12 Ecole Polytechnique Fédérale De Lausanne (Epfl) Epfl-Tto Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US11253579B2 (en) 2017-06-16 2022-02-22 The University Of Chicago Compositions and methods for inducing immune tolerance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529463B1 (en) 1982-07-05 1986-01-10 Centre Nat Rech Scient METHOD AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR ALLOSTERIC EFFECTORS OF HEMOGLOBIN AND ERYTHROCYTES OBTAINED THEREBY
FR2678512B1 (en) 1991-07-03 1995-06-30 Novacell INTERNALIZING MACHINE.
DE69732225T2 (en) 1997-05-05 2005-06-23 Dideco S.R.L., Mirandola Process for the encapsulation of biologically active substances in erythrocytes and apparatus therefor
FR2873925B1 (en) * 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions METHOD AND DEVICE FOR LYSE-RESCALING FOR THE INCORPORATION OF ACTIVE PRINCIPLE, IN PARTICULAR ASPARAGINASE OR INOSITOL HEXAPHOSPHATE, IN ERYTHROCYTES
FR2884717B1 (en) 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions ERYTHROCYTES CONTAINING ARGININE DEIMINASE
FR2891843A1 (en) 2005-10-06 2007-04-13 Erytech Pharma Soc Par Actions ERYTHROCYTES CONTAINING 5-FLUOROURACILE
WO2007097934A2 (en) * 2006-02-17 2007-08-30 Elusys Therapeutics, Inc. Methods and compositions for using erythrocytes as carriers for delivery of drugs

Also Published As

Publication number Publication date
WO2010076517A1 (en) 2010-07-08
FR2940087A1 (en) 2010-06-25

Similar Documents

Publication Publication Date Title
LTC2358756I2 (en) HUMAN RELIABLE HUMAN ANTIBODIES PCSK9
FR2941231B1 (en) NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES
BRPI0911351A2 (en) sent structure and valve prosthesis.
BRPI0815773A2 (en) compound and medicine.
NO2021006I1 (en) Quofenix, delafloxacin
BRPI0923823A2 (en) Collaboration Agent.
BRPI0906474A2 (en) Certain chemical entities, compositions and methods
ATE540040T1 (en) DIOXABICYCLOÄ3.2.1ÜOCTANE-2,3,4-TRIOL DERIVATIVES
BRPI0923231A2 (en) anti-cmet antibody.
BRPI0909084A2 (en) Liquid composition, and, peptide compound.
BRPI0918122A2 (en) diaboy molecule, diaboy, and dart molecule
BRPI0807473A2 (en) CONTAINER, JAVRE AND CONTAINER AND JAVRE ASSEMBLY
FR2940087B1 (en) ERYTHROCYTES CONTAINING FACTOR VIII, PREPARATION AND USES.
BRPI0913112A2 (en) flowmeter and method.
BRPI0807991A2 (en) PREPARED ANTI-IL-23R ANTIBODIES.
ATE503759T1 (en) 7-Ä2-Ä4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOLE-5-YL - 1-PIPERAZINYLÜETHYLÜ-2-(1-PROPINYL)-7H-PYRAZOLO
BRPI0815922A2 (en) ARTICLE, COMPOSITION, AND METHOD.
CO6241120A2 (en) (DIHIDRO) PIRROLO [2,1-á] ISOQUINOLINAS.
BRPI0911252A2 (en) Method, extract, and composition.
CR10526S (en) CONTAINER
CL2008000689S1 (en) BREAST PROTESIS
BRPI0914584A2 (en) Method, and, herbicidal composition.
NL2002365A1 (en) Flow splitter and reaction assembly.
JP2013541099A5 (en)
BRPI0809684A2 (en) PACKING, AND PACKING

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829